UBS Group
AFJKR icon

UBS Group’s Aimei Health Technology Co Right AFJKR Stock Holding History

UBS Group’s Portfolio AFJKR Stock Details AFJKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,447
Closed -$754 – 10410
2026
Q1 		$754 Sell
2,447
-1,008
-29% -$376 ﹤0.01% 9757
2025
Q4 		$1.29K Sell
3,455
-43,223
-93% -$16.3K ﹤0.01% 9638
2025
Q3 		$14.9K Sell
46,678
-7,285
-13% -$2.62K ﹤0.01% 8339
2025
Q2 		$13K Hold
53,963
– – ﹤0.01% 8718
2025
Q1 		$12.1K Buy
+53,963
New +$13.8K ﹤0.01% 8510

Other funds holding AFJKR

Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Harraden Circle Investments
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

UBS Group's AFJKR Position: Q2 2026 in Review

UBS Group sold out of Aimei Health Technology Co Right (AFJKR) in Q2 2026, closing a stake of 2,447 shares — an estimated $754 sold.

UBS Group first reported a position in AFJKR in Q1 2025 and held it in 5 quarters. The position peaked at $14.9K in Q3 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

  • UBS Group reported no remaining Aimei Health Technology Co Right position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 2,447 Aimei Health Technology Co Right shares in Q2 2026, an estimated $754.
  • UBS Group first reported a position in Aimei Health Technology Co Right in Q1 2025 and held it in 5 quarters.
  • UBS Group's Aimei Health Technology Co Right position peaked at $14.9K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.